446 related articles for article (PubMed ID: 27686084)
1. Markers of endothelial dysfunction and leucocyte activation in Saudi and non-Saudi haplotypes of sickle cell disease.
Al Najjar S; Adam S; Ahmed N; Qari M
Ann Hematol; 2017 Jan; 96(1):141-146. PubMed ID: 27686084
[TBL] [Abstract][Full Text] [Related]
2. Plasma PTX3 levels in sickle cell disease patients, during vaso occlusion and acute chest syndrome (data from Saudi population).
Elshazly SA; Heiba NM; Abdelmageed WM
Hematology; 2014 Jan; 19(1):52-9. PubMed ID: 23735470
[TBL] [Abstract][Full Text] [Related]
3. Dynamics of von Willebrand factor reactivity in sickle cell disease during vaso-occlusive crisis and steady state.
Sins JWR; Schimmel M; Luken BM; Nur E; Zeerleder SS; van Tuijn CFJ; Brandjes DPM; Kopatz WF; Urbanus RT; Meijers JCM; Biemond BJ; Fijnvandraat K
J Thromb Haemost; 2017 Jul; 15(7):1392-1402. PubMed ID: 28457019
[TBL] [Abstract][Full Text] [Related]
4. Endothelial activation and inflammation biomarkers in children and adolescents with sickle cell disease.
Hatzipantelis ES; Pana ZD; Gombakis N; Taparkou A; Tzimouli V; Kleta D; Zafeiriou DJ; Garipidou V; Kanakoudi F; Athanassiou M
Int J Hematol; 2013 Aug; 98(2):158-63. PubMed ID: 23807289
[TBL] [Abstract][Full Text] [Related]
5. Levels of Soluble Endothelium Adhesion Molecules and Complications among Sickle Cell Disease Patients in Ghana.
Antwi-Boasiako C; Donkor ES; Sey F; Dzudzor B; Dankwah GB; Otu KH; Doku A; Dale CA; Ekem I
Diseases; 2018 Apr; 6(2):. PubMed ID: 29690499
[TBL] [Abstract][Full Text] [Related]
6. Relationship between the clinical manifestations of sickle cell disease and the expression of adhesion molecules on white blood cells.
Okpala I; Daniel Y; Haynes R; Odoemene D; Goldman J
Eur J Haematol; 2002 Sep; 69(3):135-44. PubMed ID: 12406006
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of reticulated platelets in patients with sickle cell diseases.
Noronha JF; Costa FF; Saad ST; Lorand-Metze IG; Grotto HZ
Thromb Res; 2007; 121(2):259-67. PubMed ID: 17521711
[TBL] [Abstract][Full Text] [Related]
8. Low nitric oxide level is implicated in sickle cell disease and its complications in Ghana.
Antwi-Boasiako C; Campbell AD
Vasc Health Risk Manag; 2018; 14():199-204. PubMed ID: 30233199
[TBL] [Abstract][Full Text] [Related]
9. Levels of soluble endothelium-derived adhesion molecules in patients with sickle cell disease are associated with pulmonary hypertension, organ dysfunction, and mortality.
Kato GJ; Martyr S; Blackwelder WC; Nichols JS; Coles WA; Hunter LA; Brennan ML; Hazen SL; Gladwin MT
Br J Haematol; 2005 Sep; 130(6):943-53. PubMed ID: 16156864
[TBL] [Abstract][Full Text] [Related]
10. Cytokine profile of sickle cell disease in Oman.
Pathare A; Al Kindi S; Alnaqdy AA; Daar S; Knox-Macaulay H; Dennison D
Am J Hematol; 2004 Dec; 77(4):323-8. PubMed ID: 15551290
[TBL] [Abstract][Full Text] [Related]
11. Endothelial function in patients with sickle cell anemia during and after sickle cell crises.
Blum A; Yeganeh S; Peleg A; Vigder F; Kryuger K; Khatib A; Khazim K; Dauerman H
J Thromb Thrombolysis; 2005 Apr; 19(2):83-6. PubMed ID: 16052296
[TBL] [Abstract][Full Text] [Related]
12. Flow adhesion of whole blood to P-selectin: a prognostic biomarker for vaso-occlusive crisis in sickle cell disease.
Hines PC; Callaghan MU; Zaidi AU; Gao X; Liu K; White J; Tarasev M
Br J Haematol; 2021 Sep; 194(6):1074-1082. PubMed ID: 34472086
[TBL] [Abstract][Full Text] [Related]
13. Pattern of serum cytokine expression and T-cell subsets in sickle cell disease patients in vaso-occlusive crisis.
Musa BO; Onyemelukwe GC; Hambolu JO; Mamman AI; Isa AH
Clin Vaccine Immunol; 2010 Apr; 17(4):602-8. PubMed ID: 20130127
[TBL] [Abstract][Full Text] [Related]
14. Plasma levels of TNF-alpha in sickle cell patients receiving hydroxyurea.
Tavakkoli F; Nahavandi M; Wyche MQ; Perlin E
Hematology; 2004 Feb; 9(1):61-4. PubMed ID: 14965870
[TBL] [Abstract][Full Text] [Related]
15. Arterialization of venous blood for differentiation of sickle cell subjects in vaso-occlusive crisis.
Nahavandi M; Tavakkoli F; Wyche MQ; Perlin E; Millis RM
Hematology; 2003 Dec; 8(6):421-8. PubMed ID: 14668039
[TBL] [Abstract][Full Text] [Related]
16. Protein Z polymorphisms associated with vaso-occlusive crisis in young sickle cell disease patients.
Mahdi N; Abu-Hijleh TM; Abu-Hijleh FM; Sater MS; Al-Ola K; Almawi WY
Ann Hematol; 2012 Aug; 91(8):1215-20. PubMed ID: 22576309
[TBL] [Abstract][Full Text] [Related]
17. Adhesion molecules and high-sensitivity C-reactive protein levels in patients with sickle cell beta-thalassaemia.
Kanavaki I; Makrythanasis P; Lazaropoulou C; Kattamis A; Tzanetea R; Kalotychou V; Rombos I; Papassotiriou I
Eur J Clin Invest; 2012 Jan; 42(1):27-33. PubMed ID: 21615396
[TBL] [Abstract][Full Text] [Related]
18. Serum IL-6, IL-10, and TNFα levels in pediatric sickle cell disease patients during vasoocclusive crisis and steady state condition.
Sarray S; Saleh LR; Lisa Saldanha F; Al-Habboubi HH; Mahdi N; Almawi WY
Cytokine; 2015 Mar; 72(1):43-7. PubMed ID: 25569375
[TBL] [Abstract][Full Text] [Related]
19. Patterns of arginine and nitric oxide in patients with sickle cell disease with vaso-occlusive crisis and acute chest syndrome.
Morris CR; Kuypers FA; Larkin S; Vichinsky EP; Styles LA
J Pediatr Hematol Oncol; 2000; 22(6):515-20. PubMed ID: 11132219
[TBL] [Abstract][Full Text] [Related]
20. Sickle cell vaso-occlusive crisis is associated with abnormalities in the ratio of vasoconstrictor to vasodilator prostanoids.
Setty BN; Chen D; Stuart MJ
Pediatr Res; 1995 Jul; 38(1):95-102. PubMed ID: 7478805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
